MedPath

Evaluation of the course of COVID-19 and perceptions among those tested positive – a survey based study

Conditions
U07.1
COVID-19, virus identified
Registration Number
DRKS00022926
Lead Sponsor
Ruprecht-Karls-Universität Heidelberg
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
897
Inclusion Criteria

Patients with confirmed SARS-CoV-2 infection by PCR (or rapid test when available) diagnosis from nasopharynx, oropharynx, stool, or blood at the completion of their isolation period OR first degree relatives of these patients (in case of patient death)

Exclusion Criteria

• No consent
• No ability to communicate in a language adequate for the patient

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Investigate the course of illness and assess potential risk factors for a complicated course and associated timing<br>2. Understand the rapidity of diagnosis from onset of symptoms<br>3. Investigate perspectives of patients with COVID-19 on their disease and their ability to isolate
Secondary Outcome Measures
NameTimeMethod
1. Assess clinical and sociodemographic characteristics of patients with COVID-19<br>2. Monitoring different trends over time (symptoms, incidence)<br>3. Assessment of regional differences in management and clinical outcome<br>4. Assessment of the temporal relationship between the severity of SARS-CoV-2 infection and death<br>5. To assess the economic burden of disease to the patient<br>6. Estimate of direct health care costs based on length of stay, time on ICU, time with mechanical ventilation<br>7. Assess the ability to comply with isolation methods<br>8. Understand the sequence and reversibility of symptoms (descriptive) to informs screening algorithms
© Copyright 2025. All Rights Reserved by MedPath